Apolipoproteins as Predictors of Ischaemic Stroke in Patients With a Previous Transient Ischaemic Attack

In patients who have already had a warning stroke — a transient ischemic attack — predicting who will go on to a full stroke is high-stakes. This study tested whether apolipoprotein measures do that job better than the usual cholesterol panel.

Following 261 TIA patients, the investigators found that the apoB/apoA1 ratio was the single strongest independent predictor of future ischemic stroke, nearly tripling the risk in the highest group, with apoB alone close behind. Strikingly, the traditional lipid measures — total cholesterol, LDL, HDL — showed no significant association with stroke risk in this cohort at all. Where the standard panel was silent, the apolipoprotein measures spoke clearly.

The result fits the broader case that apoB and its ratio capture atherogenic risk that conventional cholesterol numbers can miss — here, in the specific and dangerous setting of cerebrovascular disease.

We rate the evidence moderate. The cohort is small and the finding needs larger confirmation, but it adds a stroke-specific data point to the consistent signal that counting atherogenic particles outperforms measuring cholesterol content.